Nitric oxide synthase activity in human lung cancer

Japanese Journal of Cancer Research

Volumn 88, Issue 12, 1997, Pages 1190-1198

  Fujimoto, Hisao ^a   Ando, Yukio ^a   Yamashita, Taro ^a   Terazaki, Hisayasu ^a   Tanaka, Yoshiya ^a   Sasaki, Jiichiro ^a   Matsumoto, Mitsuhiro ^a   Suga, Moritaka ^a   Ando, Masayuki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Human; Lung cancer; Nitric oxide; Nitric oxide synthase

Indexed keywords

NITRIC OXIDE SYNTHASE;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CARCINOID; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG PARENCHYMA; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 0031460717     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00348.x     Document Type: Article

References (35)

1. Palmer, R. M. J., Ferrige, A. G. and Moncada, S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 327, 524-526 (1987).
2. Moncada, S., Palmer, R. M. J. and Higgs, E. J. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43, 109-142 (1991).
3. Moncada, S. and Higgs, A. The L-arginine-nitric oxide pathway. N. Engl. J. Med., 329, 2002-2112 (1993).
4. Knowles, R. G. and Moncada, S. Nitric oxide synthases in mammals. Biochem. J., 298, 249-258 (1994).
5. Sakuma, I., Stuehr, D. J., Gross, S. S., Nathan, C. and Levi, R. Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. USA, 85, 8664-8667 (1988).
6. Nava, E., Palmer, R. M. and Moncada, S. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet, 338, 1555-1557 (1991).
7. Forstermann, U., Gorsky, L. D., Pollock, J. S., Ishii, K., Schmidt, H. H. H. W., Heller, M. and Murad, F. Hormone-induced biosynthesis of endothelium-derived relaxing factor/nitric oxide-like material in N1E-115 neuroblastoma cells requires calcium and calmodulin. Mol. Pharmacol., 38, 7-13 (1990).
8. 2+/calmodulin-dependent nitric oxide synthase activity in the human cervix cell line ME-180. Biochem. J., 289, 357-361 (1993).
9. Jenkins, D. C., Charles, I. G., Baylis, I. A., Lelchuk, R., Radomski, M. W. and Moncada, S. Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br. J. Cancer, 70, 847-849 (1994).
10. Amber, I. J., Hibbs, J. B., Jr., Taintor, R. R. and Vavrin, Z. The L-arginine dependent effector mechanism is induced in murine adenocarcinoma cells by culture supernatant from cytotoxic activated macrophages. J. Leukocyte Biol., 43, 187-192 (1988).
11. Radomski, M. W., Jenkins, D. C., Holmes, L. and Moncada, S. Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res., 51, 6073-6078 (1991).
12. Sherman, P. A., Laubach, V. E., Reep, B. R. and Wood, E. R. Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line. Biochemistry, 32, 11600-11605 (1993).
13. Thomsen, L. L., Lawton, F. G., Knowles, R. G., Beealey, J. E., Riveros, M. V. and Moncada, S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res., 54, 1352-1354 (1994).
14. Cobbs, C. S., Brenman, J. E., Aldape, D., Bredt, S. B. and Israel, A. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res., 55, 727-730 (1995).
15. Thomsen, L. L., Miles, D. W., Happerfield, L., Bobrow, L. G., Knowles, R. G. and Moncada, S. Nitric oxide synthase activity in human breast cancer. Br. J. Cancer, 72, 41-44 (1995).
16. Xie, K. and Fidler, I. J. Induction of apoptosis in transformed fibroblasts can be mediated via endogenous and exogenous nitric oxide. Proc. Am. Assoc. Cancer Res., 34, 95 (1993).
17. Andrade, S., Hart, I. and Piper, P. Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature. Br. J. Pharmacol., 107, 1092-1095 (1992).
18. Maeda, H., Noguchi, Y., Sato, K. and Akaike, T. Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor. Jpn. J. Cancer Res., 85, 331-334 (1994).
19. Kubes, P. and Granger, D. Nitric oxide modulates microvascular permeability. Am. J. Physiol., 262, 611-615 (1992).
20. Jenkins, D. C., Charles, I. G., Thomsen, L. L., Moss, D. W., Holmes, L. S., Baylis, S. A., Rhodes, P., Westmore, K., Emson, P. C. and Moncada, S. Roles of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. USA, 92, 4392-4396 (1995).
21. World Health Organization. The World Health Organization histological typing of lung cancer. Am. J. Clin. Pathol., 77, 123-136 (1982).
22. Isobe, Y., Chen, S. T., Nakane, P. K. and Brown, W. R. Studies on translocation of immunoglobulins across intestinal epithelium I. Improvements in the peroxidase-labeled antibody method for application to study of human intestinal mucosa. Acta Histochem. Cytochem., 10, 161-171 (1977).
23. Bredt, D. S. and Snyder, S. H. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. USA, 86, 9030-9033 (1989).
24. Asano, K., Chee, C. B. E., Gaston, B., Lilly, C. M., Gerard, C., Drazen, J. M. and Stamler, J. S. Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc. Natl. Acad. Sci. USA, 91, 10089-10093 (1994).
25. Shaul, P. W., North, A. J., Wu, L. C., Wells, L. B., Brannon, T. S., Lau, K. S., Michel, T., Margraf, L. R. and Star, R. A. Endothelial nitric oxide synthase is expressed in cultured human bronchiolar epithelium. J. Clin. Invest., 94, 2231-2236 (1994).
26. Fidler, I. J. Critical factors in the biology of human cancer metastasis. Cancer Res., 50, 6130-6138 (1990).
27. Nicolson, G. Cancer metastasis: tumor cells and host-organ properties important in metastasis to specific secondary sites. Biochim. Biophys. Acta, 948, 175-224 (1986).
28. Radinsky, R. Growth factors and their receptors in metastasis. Semin. Cancer Biol., 2, 169-177 (1991).
29. Dong, Z., Staroselsky, A. H., Qi, X., Xie, K. and Fidler, I. J. Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res., 54, 789-793 (1994).
30. Palmer, R. M. J., Rees, D. D., Ashton, D. S. and Moncada, S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature, 333, 664-666 (1988).
31. Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E. and Chaudhuri, G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA, 87, 5193-5197 (1990).
32. Weidner, N., Folkman, J., Pozza, F., Pierantonio, B., Allred, E. N., Moore, D. H., Meli, S. and Gasparini, G. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst., 84, 1875-1887 (1992).
33. Radomski, M. W., Palmar, R. M. J. and Moncada, S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. USA, 87, 5193-5197 (1990).
34. Radomski, M. W., Palmar, R. M. J. and Moncada, S. Characterization of the L-arginine:nitric oxide pathway in human platelets. Br. J. Pharmacol., 101, 325-328 (1990).
35. Sugimoto, Y., Oh-hara, T., Watanabe, M., Uamori, T. and Tsuruo, T. Acquisition of metastatic ability in hybridomas between two low metastatic clones of murine colon adenocarcinoma 26 defective in either platelet-aggregating activity or in vivo growth potential. Cancer Res., 47, 3115-3117 (1987).